Cell Discovery (Mar 2024)
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activities
- Claudio Pulito,
- Federica Mori,
- Andrea Sacconi,
- Frauke Goeman,
- Maria Ferraiuolo,
- Patrizia Pasanisi,
- Carlo Campagnoli,
- Franco Berrino,
- Maurizio Fanciulli,
- Rebecca J. Ford,
- Massimo Levrero,
- Natalia Pediconi,
- Ludovica Ciuffreda,
- Michele Milella,
- Gregory R. Steinberg,
- Mario Cioce,
- Paola Muti,
- Sabrina Strano,
- Giovanni Blandino
Affiliations
- Claudio Pulito
- Molecular Chemoprevention Unit, Italian National Cancer Institute ‘Regina Elena’
- Federica Mori
- Molecular Chemoprevention Unit, Italian National Cancer Institute ‘Regina Elena’
- Andrea Sacconi
- Oncogenomic and Epigenetic Unit, Italian National Cancer Institute ‘Regina Elena’
- Frauke Goeman
- Oncogenomic and Epigenetic Unit, Italian National Cancer Institute ‘Regina Elena’
- Maria Ferraiuolo
- Molecular Chemoprevention Unit, Italian National Cancer Institute ‘Regina Elena’
- Patrizia Pasanisi
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori
- Carlo Campagnoli
- Unit of Endocrinological Gynecology, Ospedale Sant’Anna di Torino
- Franco Berrino
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori
- Maurizio Fanciulli
- SAFU, ‘Regina Elena’ National Cancer Institute
- Rebecca J. Ford
- Division of Endocrinology and Metabolism, Department of Medicine, McMaster University
- Massimo Levrero
- Epigénétique et Épigénomique des Carcinomes Hépathocellulaires Viro-Induits du Centre de Recherche en Cancérologie de Lyon
- Natalia Pediconi
- Department of Molecular Medicine, Sapienza University of Rome
- Ludovica Ciuffreda
- Division of Medical Oncology A, Italian National Cancer Institute ‘Regina Elena’
- Michele Milella
- Division of Medical Oncology A, Italian National Cancer Institute ‘Regina Elena’
- Gregory R. Steinberg
- Division of Endocrinology and Metabolism, Department of Medicine, McMaster University
- Mario Cioce
- Oncogenomic and Epigenetic Unit, Italian National Cancer Institute ‘Regina Elena’
- Paola Muti
- Department of Oncology, Juravinski Cancer Center, McMaster University
- Sabrina Strano
- Molecular Chemoprevention Unit, Italian National Cancer Institute ‘Regina Elena’
- Giovanni Blandino
- Oncogenomic and Epigenetic Unit, Italian National Cancer Institute ‘Regina Elena’
- DOI
- https://doi.org/10.1038/s41421-024-00655-2
- Journal volume & issue
-
Vol. 10,
no. 1
pp. 1 – 8
Abstract
No abstracts available.
